Today during trading, shares of Eupraxia Pharmaceuticals Inc opened at $3.81 and closed at $3.75. It traded at a low of $3.68 to a high of $3.90.

The price eased -2.60 percent from the previous day's close of $3.85.

Today across North America, the TSX Composite closed -0.73% at 22199.13, the S&P 500 closed -0.95% at 5160.64, the Dow Jones Industrial Average closed -1.09% at 38461.51 and the Nasdaq Composite closed -0.84% at 16170.36.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

Trading volume was 45,000 on 55 total trades, while having an average volume of 67,765 over 5 days.

The TSX overall saw 2,898 price advancers against 2,320 declines and 129 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.68 (April 11,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have dipped -16.29 percent, while they have shrunken -30.17% year-to-date.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $137.15 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..